INMUNE BIO INC
INMUNE BIO INC logo
INMB

INMUNE BIO INC (INMB)

$6.73.08%

Market is closed
– opens on 8 PM, 06 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$6.59
Day's Range
$7.0
$4.63
52-Week Range
$12.73
1 month return15.62%
3 month return12.59%
1 year return40.18%
5 year return70.83%

Company Information

INmune Bio, Inc. is a publicly traded, clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and mechanistic target of many diseases. The Natural Killer Cell Priming Platform includes INKmune™ aimed at priming the patient's NK cells to eliminate minimal residual disease in patients with cancer. INmune Bio's product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation.
OrganizationINMUNE BIO INC
Employees10
CEODr. Raymond Joseph Tesi M.D.
IndustryMedical Specialties

Analyst Recommendation

based on 4 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for INMUNE BIO INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 113.88%

Current

$6.7

Target

$14.33

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
4
7
7
Hold
0
2
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
124.1M
Book Value
$3.55
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.92
Wall Street Target Price
14.33

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.95
Enterprise Value
82.0M
Enterprise Value/Revenue
186.45
Enterprise Value/Ebitda
-2.8

Technicals

Beta
2.02
50 Day MA
7.03
200 Day MA
7.92

Institutional Holdings

Vanguard Group Inc

3.02%

BlackRock Inc

1.3%

Janney Montgomery Scott LLC

1.09%

ACT Capital Management, LLC

0.84%

Geode Capital Management, LLC

0.77%

Morgan Stanley - Brokerage Accounts

0.72%

Discover more

Frequently Asked Questions

What is INMUNE BIO INC share price today?

Can Indians buy INMUNE BIO INC shares?

How can I buy INMUNE BIO INC shares from India?

Can Fractional shares of INMUNE BIO INC be purchased?

What are the documents required to start investing in INMUNE BIO INC stocks?

What are today’s High and Low prices of INMUNE BIO INC?

What are today’s traded volumes of INMUNE BIO INC?

What is today’s market capitalisation of INMUNE BIO INC?

What is the 52 Week High and Low Range of INMUNE BIO INC?

How much percentage INMUNE BIO INC is down from its 52 Week High?

How much percentage INMUNE BIO INC is up from its 52 Week low?

What are the historical returns of INMUNE BIO INC?

Who is the Chief Executive Officer (CEO) of INMUNE BIO INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*